bp3 protein
163-BP3 |
|||
T29288-1g | TargetMol Chemicals | 1g | Ask for price |
Description: 163-BP3 |
|||
163-BP3 |
|||
T29288-1mg | TargetMol Chemicals | 1mg | Ask for price |
Description: 163-BP3 |
|||
163-BP3 |
|||
T29288-50mg | TargetMol Chemicals | 50mg | Ask for price |
Description: 163-BP3 |
|||
163-BP3 |
|||
T29288-5mg | TargetMol Chemicals | 5mg | Ask for price |
Description: 163-BP3 |
|||
IGF-BP3 Recombinant Protein |
|||
40-153-0005mg | ProSci | 0.005 mg | 311.1 EUR |
Description: IGF-BP3 is a 30 kDa cysteine-rich secreted protein. It is the major IGF binding protein present in the plasma of human and animals and it is also found in α-granules of platelets. In addition to its ability to modulate the activity of IGF-I and IGF-II, IGF-BP3 exerts inhibitory effects on follicle stimulating hormone (FSH) activity. Decreased plasma levels of IGF-BP3 often results in dwarfism, whereas elevated levels of IGF-BP3 may lead to acromegaly. The expression of IGF-BP3 in fibroblasts is stimulated by mitogenic growth factors such as Bombesin, Vasopressin, PDGF, and EGF. Recombinant human IGF-BP3 is a 28.8 kDa protein consisting of 264 amino acid residues. |
|||
IGF-BP3 Recombinant Protein |
|||
40-153-0025mg | ProSci | 0.025 mg | 437.1 EUR |
Description: IGF-BP3 is a 30 kDa cysteine-rich secreted protein. It is the major IGF binding protein present in the plasma of human and animals and it is also found in α-granules of platelets. In addition to its ability to modulate the activity of IGF-I and IGF-II, IGF-BP3 exerts inhibitory effects on follicle stimulating hormone (FSH) activity. Decreased plasma levels of IGF-BP3 often results in dwarfism, whereas elevated levels of IGF-BP3 may lead to acromegaly. The expression of IGF-BP3 in fibroblasts is stimulated by mitogenic growth factors such as Bombesin, Vasopressin, PDGF, and EGF. Recombinant human IGF-BP3 is a 28.8 kDa protein consisting of 264 amino acid residues. |
|||
Human IGF-BP3 Recombinant Protein |
|||
100-199 | ReliaTech | 25 µg | 196.35 EUR |
Description: Human IGF-BP3, also known as growth-hormone-dependant binding protein, is 28.9 kDa cysteine-rich secreted protein. It is the major IGF binding protein present in the plasma of human and animals and it is also found in alpha-granules of platelets. In addition to its ability to modulate the activity of IGF-I and IGF-2, IGF-BP3 exerts inhibitory effects on follicle stimulating hormone (FSH) activity. Decreased plasma levels of IGF-BP3 often results in dwarfism, whereas elevated levels of IGF-BP3 may lead to acromegaly. The expression of IGF-BP3 in fibroblasts is stimulated by mitogenic growth factors such as Bombesin, Vasopressin, PDGF and EGF. Recombinant human IGF-BP3 is a 28.8 kDa protein consisting of 264 amino acid residues. |
|||
Human IGF-BP3 Recombinant Protein |
|||
100-199S | ReliaTech | 5 µg | 92.4 EUR |
Description: Human IGF-BP3, also known as growth-hormone-dependant binding protein, is 28.9 kDa cysteine-rich secreted protein. It is the major IGF binding protein present in the plasma of human and animals and it is also found in alpha-granules of platelets. In addition to its ability to modulate the activity of IGF-I and IGF-2, IGF-BP3 exerts inhibitory effects on follicle stimulating hormone (FSH) activity. Decreased plasma levels of IGF-BP3 often results in dwarfism, whereas elevated levels of IGF-BP3 may lead to acromegaly. The expression of IGF-BP3 in fibroblasts is stimulated by mitogenic growth factors such as Bombesin, Vasopressin, PDGF and EGF. Recombinant human IGF-BP3 is a 28.8 kDa protein consisting of 264 amino acid residues. |
|||
Recombinant Human IGF-BP3 Protein |
|||
PROTP17936-2 | BosterBio | 25ug | 380.4 EUR |
Description: IGF-BP3 is a 30 kDa cysteine-rich secreted protein. It is the major IGF binding protein present in the plasma of human and animals and it is also found in α-granules of platelets. In addition to its ability to modulate the activity of IGF-I and IGF-II, IGF-BP3 exerts inhibitory effects on follicle stimulating hormone (FSH) activity. Decreased plasma levels of IGF-BP3 often results in dwarfism, whereas elevated levels of IGF-BP3 may lead to acromegaly. The expression of IGF-BP3 in fibroblasts is stimulated by mitogenic growth factors such as Bombesin, Vasopressin, PDGF, and EGF. Recombinant human IGF-BP3 is a 28.8 kDa protein consisting of 264 amino acid residues. |
|||
anti-p53 BP3 |
|||
YF-PA25512 | Abfrontier | 50 ul | 400.8 EUR |
Description: Mouse polyclonal to p53 BP3 |
|||
IGF BP3 antibody |
|||
70R-IR022 | Fitzgerald | 50 ug | 312 EUR |
Description: Affinity purified Rabbit polyclonal IGF BP3 antibody |
|||
Human IGF-BP3 Recombinant Protein Lyophilized |
|||
IHUIGFBP3RLY5UG | Innovative research | each | 341 EUR |
Description: Human IGF-BP3 Recombinant Protein Lyophilized |
|||
Anti-p53 BP3 (4G4) |
|||
YF-MA17183 | Abfrontier | 100 ug | 435.6 EUR |
Description: Mouse monoclonal to p53 BP3 |
|||
Anti-p53 BP3 (6E7) |
|||
YF-MA17184 | Abfrontier | 100 ug | 435.6 EUR |
Description: Mouse monoclonal to p53 BP3 |
|||
Anti-p53 BP3 (1A5) |
|||
YF-MA17185 | Abfrontier | 100 ug | 435.6 EUR |
Description: Mouse monoclonal to p53 BP3 |
|||
Anti-p53 BP3 (5G9) |
|||
YF-MA17186 | Abfrontier | 50 ug | 435.6 EUR |
Description: Mouse monoclonal to p53 BP3 |
|||
Anti-p53 BP3 (5G9) |
|||
YF-MA17187 | Abfrontier | 200 ul | 435.6 EUR |
Description: Mouse monoclonal to p53 BP3 |
|||
Anti-p53 BP3 (6D2) |
|||
YF-MA17188 | Abfrontier | 100 ug | 435.6 EUR |
Description: Mouse monoclonal to p53 BP3 |
|||
Anti-p53 BP3 (6C8) |
|||
YF-MA17189 | Abfrontier | 100 ug | 435.6 EUR |
Description: Mouse monoclonal to p53 BP3 |
|||
Anti-p53 BP3 (6B7) |
|||
YF-MA17191 | Abfrontier | 100 ug | 435.6 EUR |
Description: Mouse monoclonal to p53 BP3 |
|||
Anti-p53 BP3 (5G11) |
|||
YF-MA11257 | Abfrontier | 100 ug | 435.6 EUR |
Description: Mouse monoclonal to p53 BP3 |
|||
Anti-p53 BP3 (6F11) |
|||
YF-MA17190 | Abfrontier | 100 ug | 435.6 EUR |
Description: Mouse monoclonal to p53 BP3 |
|||
Recombinant Human IGF BP3 |
|||
HEGFP-0903 | Cyagen | 5ug | Ask for price |
Human IGF-BP3 (Animal Free) Recombinant Protein |
|||
100-199-AF | ReliaTech | 25 µg | 229.95 EUR |
Description: IGF-BP3 is a 30 kDa, cysteine-rich secreted protein. It is the major IGF binding protein present in the plasma of human and animals, and it is also found in α-granules of platelets. In addition to its ability to modulate the activity of IGF-I and IGF-II, IGF-BP3 exerts inhibitory effects on follicle stimulating hormone (FSH) activity. Decreased plasma levels of IGF-BP3 often results in dwarfism, whereas elevated levels of IGF-BP3 may lead to acromegaly. The expression of IGF-BP3 in fibroblasts is stimulated by mitogenic growth factors, such as Bombesin, Vasopressin, PDGF, and EGF. Recombinant Human IGF-BP3 is a 28.8 kDa protein consisting of 264 amino acid residues. |
|||
Human IGF-BP3 (Animal Free) Recombinant Protein |
|||
100-199S-AF | ReliaTech | 5 µg | 134.4 EUR |
Description: IGF-BP3 is a 30 kDa, cysteine-rich secreted protein. It is the major IGF binding protein present in the plasma of human and animals, and it is also found in α-granules of platelets. In addition to its ability to modulate the activity of IGF-I and IGF-II, IGF-BP3 exerts inhibitory effects on follicle stimulating hormone (FSH) activity. Decreased plasma levels of IGF-BP3 often results in dwarfism, whereas elevated levels of IGF-BP3 may lead to acromegaly. The expression of IGF-BP3 in fibroblasts is stimulated by mitogenic growth factors, such as Bombesin, Vasopressin, PDGF, and EGF. Recombinant Human IGF-BP3 is a 28.8 kDa protein consisting of 264 amino acid residues. |
|||
4E BP3 Mouse Monoclonal Antibody |
|||
E10G20638 | EnoGene | 100 μl | 275 EUR |
Description: Biotin-Conjugated, FITC-Conjugated , AF350 Conjugated , AF405M-Conjugated ,AF488-Conjugated, AF514-Conjugated ,AF532-Conjugated, AF555-Conjugated ,AF568-Conjugated , HRP-Conjugated, AF405S-Conjugated, AF405L-Conjugated , AF546-Conjugated, AF594-Conjugated , AF610-Conjugated, AF635-Conjugated , AF647-Conjugated , AF680-Conjugated , AF700-Conjugated , AF750-Conjugated , AF790-Conjugated , APC-Conjugated , PE-Conjugated , Cy3-Conjugated , Cy5-Conjugated , Cy5.5-Conjugated , Cy7-Conjugated Antibody |
|||
IGF-BP3 Antibody |
|||
5720-200 | Biovision | each | 379.2 EUR |
IGF-BP3 Antibody |
|||
5720-30T | Biovision | each | 175.2 EUR |
IGF-BP3, Human |
|||
HY-P7020 | MedChemExpress | 10ug | 280.8 EUR |
IGF-BP3, human |
|||
RC216-12B3 | Bio Basic | 5ug | 125.26 EUR |
p53 BP3 (TOPORS) mouse monoclonal antibody, clone 5G11 |
|||
AM20981PU-N | Origene Technologies GmbH | 50 µg | Ask for price |
IGF-BP3, human recombinant |
|||
4720-100 | Biovision | each | 744 EUR |
IGF-BP3, human recombinant |
|||
4720-1000 | Biovision | each | 3778.8 EUR |
IGF-BP3, human recombinant |
|||
4720-25 | Biovision | each | 307.2 EUR |
Anti-Human IGF-BP3 Antibody |
|||
101-M459 | ReliaTech | 100 µg | 399 EUR |
Description: The superfamily of insulin-like growth factor (IGF) binding proteins include the six high-affinity IGF binding proteins (IGFBP) and several low-affinity binding proteins referred to as IGFBP related proteins (IGFBP-rP). All IGFBP superfamily members are cysteine-rich proteins with conserved cysteine residues, which are clustered in the amino- and carboxy-terminal thirds of the molecule. IGFBPs modulate the biological activities of IGF proteins. Some IGFBPs may also have intrinsic bioactivity that is independent of their ability to bind IGF proteins. Post-translational modifications of IGFBP, including glycosylation, phosphorylation and proteolysis, have been shown to modify the affinities of the binding proteins to IGF. |
|||
Anti-Human IGF-BP3 Antibody |
|||
102-P144 | ReliaTech | 100 µg | 245.7 EUR |
Description: The superfamily of insulin-like growth factor (IGF) binding proteins include the six high-affinity IGF binding proteins (IGFBP) and several low-affinity binding proteins referred to as IGFBP related proteins (IGFBP-rP). All IGFBP superfamily members are cysteine-rich proteins with conserved cysteine residues, which are clustered in the amino- and carboxy-terminal thirds of the molecule. IGFBPs modulate the biological activities of IGF proteins. Some IGFBPs may also have intrinsic bioactivity that is independent of their ability to bind IGF proteins. Post-translational modifications of IGFBP, including glycosylation, phosphorylation and proteolysis, have been shown to modify the affinities of the binding proteins to IGF. |
|||
Anti-Mouse IGF-BP3 Antibody |
|||
103-M237 | ReliaTech | 100 µg | 399 EUR |
Description: The superfamily of insulin-like growth factor (IGF) binding proteins include the six high-affinity IGF binding proteins (IGFBP) and several low-affinity binding proteins referred to as IGFBP related proteins (IGFBP-rP). All IGFBP superfamily members are cysteine-rich proteins with conserved cysteine residues, which are clustered in the amino- and carboxy-terminal thirds of the molecule. IGFBPs modulate the biological activities of IGF proteins. Some IGFBPs may also have intrinsic bioactivity that is independent of their ability to bind IGF proteins. Post-translational modifications of IGFBP, including glycosylation, phosphorylation and proteolysis, have been shown to modify the affinities of the binding proteins to IGF. |
|||
BP-1 Protein |
|||
20-abx263543 | Abbexa |
|
|
IGF BP2 protein |
|||
30R-AI105 | Fitzgerald | 20 ug | 312 EUR |
Description: Purified recombinant Human IGF BP2 protein |
|||
IGF BP6 protein |
|||
30R-AI106 | Fitzgerald | 25 ug | 357 EUR |
Description: Purified recombinant Human IGF BP6 protein |
|||
IGF BP7 protein |
|||
30R-AI120 | Fitzgerald | 25 ug | 312 EUR |
Description: Purified recombinant Human IGF BP7 protein |
|||
IGF BP1 protein |
|||
30R-AI121 | Fitzgerald | 25 ug | 312 EUR |
Description: Purified recombinant Human IGF BP1 protein |
|||
IGF BP4 protein |
|||
30R-AI123 | Fitzgerald | 20 ug | 312 EUR |
Description: Purified recombinant Human IGF BP4 protein |
|||
IGF BP5 protein |
|||
30R-AI124 | Fitzgerald | 25 ug | 312 EUR |
Description: Purified recombinant Human IGF BP5 protein |
|||
OPPA01368-2UG - BP-1 Protein |
|||
OPPA01368-2UG | Aviva Systems Biology | 2ug | 215 EUR |
Recombinant Bordetella Pertussis BP0495 Protein (aa 1-563) |
|||
VAng-Lsx2697-inquire | Creative Biolabs | inquire | Ask for price |
Description: Bordetella Pertussis Membrane protein insertase YidC, recombinant protein. |
|||
Recombinant Bordetella Pertussis BP0150 Protein (aa 1-252) |
|||
VAng-Lsx4669-1mgEcoli | Creative Biolabs | 1 mg (E. coli) | 4819.2 EUR |
Description: Bordetella Pertussis UPF0271 protein BP0150, recombinant protein. |
|||
Recombinant Bordetella Pertussis BP0150 Protein (aa 1-252) |
|||
VAng-Lsx4669-500gEcoli | Creative Biolabs | 500 µg (E. coli) | 3261.6 EUR |
Description: Bordetella Pertussis UPF0271 protein BP0150, recombinant protein. |
|||
Recombinant Bordetella Pertussis BP0150 Protein (aa 1-252) |
|||
VAng-Lsx4669-50gEcoli | Creative Biolabs | 50 µg (E. coli) | 2222.4 EUR |
Description: Bordetella Pertussis UPF0271 protein BP0150, recombinant protein. |
|||
Recombinant Bordetella Pertussis BP2036 Protein (aa 1-133) |
|||
VAng-Lsx4670-1mgEcoli | Creative Biolabs | 1 mg (E. coli) | 3921.6 EUR |
Description: Bordetella Pertussis UPF0225 protein BP2036, recombinant protein. |
|||
Recombinant Bordetella Pertussis BP2036 Protein (aa 1-133) |
|||
VAng-Lsx4670-500gEcoli | Creative Biolabs | 500 µg (E. coli) | 2658 EUR |
Description: Bordetella Pertussis UPF0225 protein BP2036, recombinant protein. |
|||
Recombinant Bordetella Pertussis BP2036 Protein (aa 1-133) |
|||
VAng-Lsx4670-50gEcoli | Creative Biolabs | 50 µg (E. coli) | 1815.6 EUR |
Description: Bordetella Pertussis UPF0225 protein BP2036, recombinant protein. |
|||
Recombinant Bordetella Pertussis BP0824 Protein (aa 22-150) |
|||
VAng-Lsx4681-1mgEcoli | Creative Biolabs | 1 mg (E. coli) | 3865.2 EUR |
Description: Bordetella Pertussis Azurin, recombinant protein. |
|||
Recombinant Bordetella Pertussis BP0824 Protein (aa 22-150) |
|||
VAng-Lsx4681-500gEcoli | Creative Biolabs | 500 µg (E. coli) | 2614.8 EUR |
Description: Bordetella Pertussis Azurin, recombinant protein. |
|||
Recombinant Bordetella Pertussis BP0824 Protein (aa 22-150) |
|||
VAng-Lsx4681-50gEcoli | Creative Biolabs | 50 µg (E. coli) | 1786.8 EUR |
Description: Bordetella Pertussis Azurin, recombinant protein. |
|||
Recombinant Bordetella Pertussis BP3658 Protein (aa 1-384) |
|||
VAng-Lsx4682-1mgEcoli | Creative Biolabs | 1 mg (E. coli) | 5830.8 EUR |
Description: Bordetella Pertussis Deoxyguanosinetriphosphate triphosphohydrolase-like protein, recombinant protein. |
|||
Recombinant Bordetella Pertussis BP3658 Protein (aa 1-384) |
|||
VAng-Lsx4682-500gEcoli | Creative Biolabs | 500 µg (E. coli) | 3949.2 EUR |
Description: Bordetella Pertussis Deoxyguanosinetriphosphate triphosphohydrolase-like protein, recombinant protein. |
|||
Recombinant Bordetella Pertussis BP3658 Protein (aa 1-384) |
|||
VAng-Lsx4682-50gEcoli | Creative Biolabs | 50 µg (E. coli) | 2685.6 EUR |
Description: Bordetella Pertussis Deoxyguanosinetriphosphate triphosphohydrolase-like protein, recombinant protein. |
|||
Recombinant Bordetella Pertussis BP1090 Protein (aa 1-487) |
|||
VAng-Lsx4684-1mgEcoli | Creative Biolabs | 1 mg (E. coli) | 6673.2 EUR |
Description: Bordetella Pertussis UPF0061 protein BP1090, recombinant protein. |
|||
Recombinant Bordetella Pertussis BP1090 Protein (aa 1-487) |
|||
VAng-Lsx4684-500gEcoli | Creative Biolabs | 500 µg (E. coli) | 4510.8 EUR |
Description: Bordetella Pertussis UPF0061 protein BP1090, recombinant protein. |
|||
Recombinant Bordetella Pertussis BP1090 Protein (aa 1-487) |
|||
VAng-Lsx4684-50gEcoli | Creative Biolabs | 50 µg (E. coli) | 3064.8 EUR |
Description: Bordetella Pertussis UPF0061 protein BP1090, recombinant protein. |
|||
Recombinant Bordetella Pertussis BP1203 Protein (aa 1-402) |
|||
VAng-Lsx4686-1mgEcoli | Creative Biolabs | 1 mg (E. coli) | 5984.4 EUR |
Description: Bordetella Pertussis UPF0261 protein BP1203, recombinant protein. |
|||
Recombinant Bordetella Pertussis BP1203 Protein (aa 1-402) |
|||
VAng-Lsx4686-500gEcoli | Creative Biolabs | 500 µg (E. coli) | 4047.6 EUR |
Description: Bordetella Pertussis UPF0261 protein BP1203, recombinant protein. |
|||
Recombinant Bordetella Pertussis BP1203 Protein (aa 1-402) |
|||
VAng-Lsx4686-50gEcoli | Creative Biolabs | 50 µg (E. coli) | 2755.2 EUR |
Description: Bordetella Pertussis UPF0261 protein BP1203, recombinant protein. |
|||
Recombinant Bordetella Pertussis BP0521 Protein (aa 1-111) |
|||
VAng-Lsx4687-1mgEcoli | Creative Biolabs | 1 mg (E. coli) | 3738 EUR |
Description: Bordetella Pertussis UPF0339 protein BP0521, recombinant protein. |
|||
Recombinant Bordetella Pertussis BP0521 Protein (aa 1-111) |
|||
VAng-Lsx4687-500gEcoli | Creative Biolabs | 500 µg (E. coli) | 2530.8 EUR |
Description: Bordetella Pertussis UPF0339 protein BP0521, recombinant protein. |
|||
Recombinant Bordetella Pertussis BP0521 Protein (aa 1-111) |
|||
VAng-Lsx4687-50gEcoli | Creative Biolabs | 50 µg (E. coli) | 1730.4 EUR |
Description: Bordetella Pertussis UPF0339 protein BP0521, recombinant protein. |
|||
Recombinant Bordetella Pertussis BP0294 Protein (aa 1-186) |
|||
VAng-Lsx4693-1mgEcoli | Creative Biolabs | 1 mg (E. coli) | 4286.4 EUR |
Description: Bordetella Pertussis Putative 5'(3')-deoxyribonucleotidase, recombinant protein. |
|||
Recombinant Bordetella Pertussis BP0294 Protein (aa 1-186) |
|||
VAng-Lsx4693-500gEcoli | Creative Biolabs | 500 µg (E. coli) | 2910 EUR |
Description: Bordetella Pertussis Putative 5'(3')-deoxyribonucleotidase, recombinant protein. |
|||
Recombinant Bordetella Pertussis BP0294 Protein (aa 1-186) |
|||
VAng-Lsx4693-50gEcoli | Creative Biolabs | 50 µg (E. coli) | 1983.6 EUR |
Description: Bordetella Pertussis Putative 5'(3')-deoxyribonucleotidase, recombinant protein. |
|||
Recombinant Bordetella Pertussis BP2925 Protein (aa 1-289) |
|||
VAng-Lsx4694-1mgEcoli | Creative Biolabs | 1 mg (E. coli) | 5100 EUR |
Description: Bordetella Pertussis UPF0276 protein BP2925, recombinant protein. |
|||
Recombinant Bordetella Pertussis BP2925 Protein (aa 1-289) |
|||
VAng-Lsx4694-500gEcoli | Creative Biolabs | 500 µg (E. coli) | 3444 EUR |
Description: Bordetella Pertussis UPF0276 protein BP2925, recombinant protein. |
|||
Recombinant Bordetella Pertussis BP2925 Protein (aa 1-289) |
|||
VAng-Lsx4694-50gEcoli | Creative Biolabs | 50 µg (E. coli) | 2348.4 EUR |
Description: Bordetella Pertussis UPF0276 protein BP2925, recombinant protein. |
|||
Recombinant Bordetella Pertussis BP0104 Protein (aa 1-91) |
|||
VAng-Lsx4683-1mgEcoli | Creative Biolabs | 1 mg (E. coli) | 3584.4 EUR |
Description: Bordetella Pertussis UPF0250 protein BP0104, recombinant protein. |
|||
Recombinant Bordetella Pertussis BP0104 Protein (aa 1-91) |
|||
VAng-Lsx4683-500gEcoli | Creative Biolabs | 500 µg (E. coli) | 2432.4 EUR |
Description: Bordetella Pertussis UPF0250 protein BP0104, recombinant protein. |
|||
Recombinant Bordetella Pertussis BP0104 Protein (aa 1-91) |
|||
VAng-Lsx4683-50gEcoli | Creative Biolabs | 50 µg (E. coli) | 1660.8 EUR |
Description: Bordetella Pertussis UPF0250 protein BP0104, recombinant protein. |
|||
Recombinant Bordetella Pertussis BP1738 Protein (aa 1-66) |
|||
VAng-Lsx4704-1mgEcoli | Creative Biolabs | 1 mg (E. coli) | 3360 EUR |
Description: Bordetella Pertussis UPF0337 protein BP1738, recombinant protein. |
|||
Recombinant Bordetella Pertussis BP1738 Protein (aa 1-66) |
|||
VAng-Lsx4704-500gEcoli | Creative Biolabs | 500 µg (E. coli) | 2278.8 EUR |
Description: Bordetella Pertussis UPF0337 protein BP1738, recombinant protein. |
|||
Recombinant Bordetella Pertussis BP1738 Protein (aa 1-66) |
|||
VAng-Lsx4704-50gEcoli | Creative Biolabs | 50 µg (E. coli) | 1562.4 EUR |
Description: Bordetella Pertussis UPF0337 protein BP1738, recombinant protein. |
|||
Recombinant Bordetella Pertussis BP1737 Protein (aa 1-53) |
|||
VAng-Lsx4718-inquire | Creative Biolabs | inquire | Ask for price |
Description: Bordetella Pertussis UPF0391 membrane protein BP1737, recombinant protein. |
|||
Recombinant Brucella Abortus bp26 Protein (aa 29-250) |
|||
VAng-Lsx5151-1mgEcoli | Creative Biolabs | 1 mg (E. coli) | 4567.2 EUR |
Description: Brucella Abortus (strain S19) 26 kDa periplasmic immunogenic protein, recombinant protein. |
|||
Recombinant Brucella Abortus bp26 Protein (aa 29-250) |
|||
VAng-Lsx5151-500gEcoli | Creative Biolabs | 500 µg (E. coli) | 3092.4 EUR |
Description: Brucella Abortus (strain S19) 26 kDa periplasmic immunogenic protein, recombinant protein. |
|||
Recombinant Brucella Abortus bp26 Protein (aa 29-250) |
|||
VAng-Lsx5151-50gEcoli | Creative Biolabs | 50 µg (E. coli) | 2109.6 EUR |
Description: Brucella Abortus (strain S19) 26 kDa periplasmic immunogenic protein, recombinant protein. |
|||
Anti-Human IGF-BP3 Rabbit Polyclonal Antibody |
|||
TA328352 | Origene Technologies GmbH | 100 µg | Ask for price |
p53 Tumor Suppressor Protein; Clone BP53-12 (Concentrate) |
|||
RA0318-C.1 | ScyTek Laboratories | 0.1 ml | 60.07 EUR |
p53 Tumor Suppressor Protein; Clone BP53-12 (Concentrate) |
|||
RA0318-C.5 | ScyTek Laboratories | 0.5 ml | 200.66 EUR |
TP53-Binding Protein 1 (53BP1) Antibody |
|||
20-abx134689 | Abbexa |
|
|
TP53-Binding Protein 1 (53BP1) Antibody |
|||
20-abx012992 | Abbexa |
|
|
TP53-Binding Protein 1 (53BP1) Antibody |
|||
abx217599-100ug | Abbexa | 100 ug | 526.8 EUR |
TP53-Binding Protein 1 (53BP1) Antibody |
|||
abx012992-100g | Abbexa | 100 µg | 237.5 EUR |